Inventor · Laval, QC, CA

Marc-Andre Poupart

35Patents
14h-index
46Co-inventors
81Inventor score

Filing activity: Sep 20, 1993 → Aug 4, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US6323180A Hepatitis C inhibitor tri-peptides Chemistry; Metallurgy 134 Expired
US6534523B1 Hepatitis C inhibitor tri-peptides Chemistry; Metallurgy 118 Expired
US6420380B2 Hepatitis C inhibitor tri-peptides Chemistry; Metallurgy 111 Expired
US6410531B1 Hepatitis C inhibitor tri-peptides Chemistry; Metallurgy 110 Expired
US7141574B2 Viral polymerase inhibitors Chemistry; Metallurgy 70 Expired
US6767991B1 Hepatitis C inhibitor peptides Chemistry; Metallurgy 69 Expired
US6329417A Hepatitis C inhibitor tri-pepitides Chemistry; Metallurgy 51 Expired
US6329379A Hepatitis C inhibitor tri-peptides Chemistry; Metallurgy 49 Expired
US6143715A Hepatitis C inhibitor peptide analogues Chemistry; Metallurgy 43 Expired
USRE40525E1 Hepatitis C inhibitor tri-peptides General 28 Expired
US7223785B2 Viral polymerase inhibitors Chemistry; Metallurgy 22 Expired
US7098231B2 Viral polymerase inhibitors Chemistry; Metallurgy 20 Expired
US7893084B2 Viral polymerase inhibitors Chemistry; Metallurgy 18 Active
US7157486B2 Viral polymerase inhibitors Chemistry; Metallurgy 16 Expired
US7386398B2 Hepatitis C Virus NS5B polymerase inhibitor binding pocket Chemistry; Metallurgy 14 Expired
US7511157B2 Hepatitis C inhibitor dipeptide analogs Human Necessities 11 Expired
US7323470B2 Viral polymerase inhibitors Chemistry; Metallurgy 9 Expired
US7705146B2 Hepatitis C inhibitor peptide analogs Chemistry; Metallurgy 4 Active
US6291640A Peptidomimetic inhibitors of the human cytomegalovirus protease Human Necessities 4 Expired
US10981921B2 Fragment synthesis of substituted cyclic peptides Emerging Cross-Sectional Technologies 3 Active
US7576079B2 Viral polymerase inhibitors Chemistry; Metallurgy 3 Expired
US11072616B2 Cyclic peptides targeting alpha-4-beta-7 integrin Emerging Cross-Sectional Technologies 2 Active
US7696242B2 Hepatitis C inhibitor peptide analogs Human Necessities 2 Active
US8461180B2 Inhibitors of human immunodeficiency virus replication Human Necessities 2 Active
US11046695B2 Fragment synthesis of substituted cyclic peptides Emerging Cross-Sectional Technologies 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.